leptin and Graft-vs-Host-Disease

leptin has been researched along with Graft-vs-Host-Disease* in 3 studies

Reviews

1 review(s) available for leptin and Graft-vs-Host-Disease

ArticleYear
Thymic Atrophy: Experimental Studies and Therapeutic Interventions.
    Scandinavian journal of immunology, 2018, Volume: 87, Issue:1

    The thymus is essential for T cell development and maturation. It is extremely sensitive to atrophy, wherein loss in cellularity of the thymus and/or disruption of the thymic architecture occur. This may lead to lower naïve T cell output and limited TCR diversity. Thymic atrophy is often associated with ageing. What is less appreciated is that proper functioning of the thymus is critical for reduction in morbidity and mortality associated with various clinical conditions including infections and transplantation. Therefore, therapeutic interventions which possess thymopoietic potential and lower thymic atrophy are required. These treatments enhance thymic output, which is a vital factor in generating favourable outcomes in clinical conditions. In this review, experimental studies on thymic atrophy in rodents and clinical cases where the thymus atrophies are discussed. In addition, mechanisms leading to thymic atrophy during ageing as well as during various stress conditions are reviewed. Therapies such as zinc supplementation, IL7 administration, leptin treatment, keratinocyte growth factor administration and sex steroid ablation during thymic atrophy involving experiments in animals and various clinical scenarios are reviewed. Interventions that have been used across different scenarios to reduce the extent of thymic atrophy and enhance its output are discussed. This review aims to speculate on the roles of combination therapies, which by acting additively or synergistically may further alleviate thymic atrophy and boost its function, thereby strengthening cellular T cell responses.

    Topics: Aging; Animals; Atrophy; Bone Marrow Transplantation; Cytokines; Dietary Supplements; Gene Rearrangement, T-Lymphocyte; Graft vs Host Disease; Humans; Interleukin-7; Leptin; T-Lymphocytes; Thymus Gland; Zinc

2018

Other Studies

2 other study(ies) available for leptin and Graft-vs-Host-Disease

ArticleYear
Acquired partial lipoatrophy as graft-versus-host disease and treatment with metreleptin: two case reports.
    Journal of medical case reports, 2018, Dec-14, Volume: 12, Issue:1

    Acquired partial lipoatrophy has been reported after bone marrow transplantation during childhood; however, no adult cases have previously been reported. We herein report two adult cases of acquired partial lipoatrophy after transplantation.. A 28-year-old Japanese woman developed diabetic ketoacidosis and received insulin therapy after bone marrow transplantation. She manifested partial lipoatrophy of the extremities, prominent insulin resistance, hyperglycemia, hypertriglyceridemia, and fatty liver. A 40-year-old Japanese woman underwent liver transplantation from a living donor for alcoholic liver disease after abstinence from alcohol. She newly developed non-alcoholic steatohepatitis and diabetes. Non-alcoholic steatohepatitis progressed to liver failure, and a second liver transplantation from a brain-dead donor was performed at 42 years of age. She demonstrated loss of subdermal fat of the upper and lower extremities, prominent insulin resistance, hyperglycemia, and hypertriglyceridemia. In both cases, the injection of recombinant methionyl human leptin reversed all of the metabolic abnormalities.. Acquired partial lipoatrophy after transplantation is a manifestation of chronic graft-versus-host disease in adults. This entity is associated with diabetes with prominent insulin resistance and severe hypertriglycemia and can be successfully treated with metreleptin for the long term.

    Topics: Adult; Female; Graft vs Host Disease; Humans; Leptin; Lipodystrophy; Treatment Outcome

2018
High serum leptin in patients with chronic graft-versus-host disease after hematopoietic stem cell transplantation.
    Transplantation, 2004, Nov-15, Volume: 78, Issue:9

    Increased serum leptin has been described after various organ transplants, with a mechanism that is still unclear.. We measured serum leptin in 60 patients before and after allogeneic (allo) or autologous (auto) stem cell transplant (SCT) and in 60 healthy controls, matched for age and body mass index (BMI).. Serum leptin was higher in patients after SCT than before and in controls. Leptin production was higher after allo- than after auto-SCT; the presence of chronic graft-versus-host disease (cGVHD) was associated with the highest values. The physiological correlation with BMI was lost in the allogeneic setting, indicating a strong influence of factors other than the nutritional status on circulating leptin. No relationship was found between serum leptin levels and time from transplant, age, cortisol, C-reactive protein, and T-lymphocyte CD4-to-CD8 ratio. Among the cytokines secreted by type-1/type-2 T-helper lymphocytes, only serum interferon-gamma significantly correlated with serum leptin levels. Anti-leptin blocking antibodies partially inhibited T-cell activation in mixed lymphocyte reaction, suggesting a link between leptin and T-lymphocyte activation in the allo-SCT setting.. Taken together, these findings suggest that increased serum leptin concentrations may contribute to T-cell activation during development of cGVHD.

    Topics: Adolescent; Adult; CD4-CD8 Ratio; Chronic Disease; Cytokines; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leptin; Lymphocyte Culture Test, Mixed; Male; Middle Aged

2004